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Introduction
Emergency major general surgery is generally known for its
high mortality and morbidity rates [1, 2]. Segmental colectomy
is one of the seven procedures that collectively contribute to 80
% of the mortality, morbidity, and costs of emergency general
surgery [3]. For patients with left-sided obstructive colon can-
cer (LSOCC), emergency colectomy might be avoided by choos-
ing a bridge to elective surgery (BTS) strategy.
Postponing resection of LSOCC can be achieved by either co-
lonic self-expandable metal stent (SEMS) placement or the con-
struction of a decompressing stoma [4–6]. After initial relief of
the obstruction, time is created for there to be an improvement
in the patient’s condition, for accurate preoperative staging,
and to compile an experienced surgical team. Furthermore,
the distended bowel proximal to the tumor returns to its nor-
mal caliber with optimized surgical conditions to restore bowel
continuity.
The optimal timing of resection following a decompressing
intervention remains unclear. It is generally assumed that im-
provement in the patient’s clinical and intestinal condition
takes a few weeks [7]. On the other hand, concerns have been
raised regarding the risk of SEMS-related perforation if the brid-
ging interval is prolonged. In their guideline of 2014, the Euro-
pean Society of Gastrointestinal Endoscopy (ESGE) suggested a
time interval of 5–10 days from SEMS placement until elective
resection [8]. The recent update suggests an interval of ap-
proximately 2 weeks, but still as a weak recommendation, this
being largely based on expert opinion [9]. We are not aware of
any relevant literature or guideline recommendations regard-
ing the bridging interval following a decompressing stoma.
Analysis of patients with LSOCC treated between 2009 and
2016 in the Netherlands revealed substantial variability in brid-
ging intervals for both SEMSs and decompressing stomas [10],
sufficient to determine whether the bridging interval affected
outcomes such as resection-related complications, short-term
mortality, and survival [11]. Therefore, the aim of the current
study was to evaluate the recommended bridging intervals
after SEMS placement and to explore the bridging interval after
decompressing stoma within the Dutch nationwide cohort of
LSOCC, with 90-day post-resection complications as the pri-
mary outcome measure.
Methods
Study design and patient selection
A nationwide, population-based study was performed by the
Dutch Snapshot Research Group (DSRG), as described previous-
ly [10]. Each hospital in the Netherlands (n=77) was requested
to extend baseline and short-term outcome data prospectively
collected in the Dutch ColoRectal Audit (DCRA) with supple-
mentary diagnostic, procedural, and intermediate-term data
by reviewing individual patient files, using a web-based tool
that meets Dutch privacy regulations, followed by a data verifi-
cation process. This study was approved by the Institutional Re-
view Board of the Academic Medical Center in Amsterdam, The
Netherlands. Informed consent was not required owing to the
retrospective design of the study and the use of anonymized
data.
For the current study, the eligibility criteria included regis-
tered patients between 2009 and 2016 who had: (1) a colonic
obstruction causing symptoms including a distended abdo-
men, nausea, and/or vomiting, (2) with radiological signs of ob-
struction either on computed tomography (CT) or plain radio-
graph, (3) caused by a histologically proven tumor, (4) located
ABSTRACT
Background The optimal timing of resection after decom-
pression of left-sided obstructive colon cancer is unknown.
Revised expert-based guideline recommendations have
shifted from an interval of 5–10 days to approximately 2
weeks following self-expandable metal stent (SEMS) place-
ment, and recommendations after decompressing stoma
are lacking. We aimed to evaluate the recommended brid-
ging intervals after SEMS and explore the timing of resec-
tion after decompressing stoma.
Methods This nationwide study included patients regis-
tered between 2009 and 2016 in the prospective, manda-
tory Dutch ColoRectal Audit. Additional data were collected
through patient records in 75 hospitals. Only patients who
underwent either SEMS placement or decompressing sto-
ma as a bridge to surgery were selected. Technical SEMS
failure and unsuccessful decompression within 48 hours
were exclusion criteria.
Results 510 patients were included (182 SEMS, 328 de-
compressing stoma). Median bridging interval was 23 days
(interquartile range [IQR] 13–31) for SEMS and 36 days
(IQR 22–65) for decompressing stoma. Following SEMS
placement, no significant differences in post-resection
complications, hospital stay, or laparoscopic resections
were observed with resection after 11–17 days compared
with 5–10 days. Of SEMS-related complications, 48% oc-
curred in patients operated on beyond 17 days. Compared
with resection within 14 days, an interval of 14–28 days fol-
lowing decompressing stoma resulted in significantly more
laparoscopic resections, more primary anastomoses, and
shorter hospital stays. No impact of bridging interval on
mortality, disease-free survival, or overall survival was dem-
onstrated.
Conclusions Based on an overview of the data with balan-
cing of surgical outcomes and timing of adverse events, a
bridging interval of approximately 2 weeks seems appropri-
ate after SEMS placement, while waiting 2–4 weeks after
decompressing stoma further optimizes surgical conditions
for laparoscopic resection with restoration of bowel conti-
nuity.
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in the distal colon (defined as the sigmoid colon, descending
colon, or splenic flexure), (5) that was initially treated with ei-
ther a SEMS or decompressing stoma as a BTS, (6) with curative
treatment intent. Exclusion criteria were: (1) signs of bowel
perforation on CT at baseline; (2) technically unsuccessful brid-
ging intervention; and (3) clinically unsuccessful bridging inter-
vention (defined as the absence of symptom relief within 48
hours after the initial intervention).
Procedural characteristics and outcome measures
Procedural characteristics were the proportions of patients
being discharged during the bridging interval, undergoing in-
tentional laparoscopic approach, and with a primary anastomo-
sis or a stoma in situ directly after tumor resection.
The primary outcome parameter was the proportion of re-
section-related complications within 90 days after resection of
the primary tumor. The SEMS-related complication rate follow-
ing technically and clinically successful SEMS placement was
added as a primary outcome parameter for the SEMS sub-
group. Secondary outcome measures were the 90-day post-re-
section mortality rate, hospital stay after resection, 3-year dis-
ease-free survival, and 3-year overall survival.
Statistical analysis
Cumulative incidence curves with bridging interval on the x-
axis were made for selected variables: 90-day post-resection
complications, SEMS-related complications, laparoscopic ap-
proach, and primary anastomosis. Cumulative incidence curves
were made by determining the number of patients that had al-
ready been operated on, and how many of these had had an
event, according to the outcome variable concerned, for each
day since the bridging intervention. The number of patients
with an event was then divided by the total number of patients
that had been at risk until a specific time interval, and these
proportions were plotted with the time interval in days on the
x-axis and the outcome variable on the y-axis.
The procedural characteristics and outcome measures of the
SEMS and decompressing stoma groups were determined for
different bridging intervals. Bridging intervals that were ana-
lyzed for the SEMS group were: 5–10 days (2014 ESGE guide-
line) [8], 11–17 days (2020 ESGE recommendation of approxi-
mately 2 weeks) [9], and>17 days. Bridging intervals for de-
compressing stoma were chosen based on clinical relevance in
the absence of existing guideline recommendations that could
be validated: < 14 days (early, same admission), 14–28 days
(elective, more recovery time), and >28 days (delayed, possibi-
lity of neoadjuvant treatment).
Continuous variables were tested for normality using the
Kolmogorov– Smirnoff test. Normally distributed continuous
variables were reported as mean (standard deviation [SD]) and
hypotheses regarding these variables were tested with the Stu-
dent’s t test for comparison of two groups or the one-way AN-
OVA test for more than two groups. Non-normally distributed
variables were reported as medians (interquartile range [IQR]),
with hypotheses being tested with the Mann–Whitney U test
for comparison of two groups or the Kruskal Wallis test for
more than two groups. Categorical variables were reported as
percentages and hypotheses were tested with the chi-squared
or Fisher’s exact test. Differences regarding disease-free and
overall survival were assessed using the log-rank test.
A two-sided P value <0.05 was considered statistically signif-
icant. Correction for multiple testing was performed when
comparing groups of intervals by adhering to a two-sided P val-
ue <0.025 as statistically significant. All analyses were per-
formed using IBM SPSS Statistics, version 26.0 (IBM Corp., Ar-
monk, New York, USA).
Results
Baseline characteristics
A total of 75 of 77 hospitals provided supplementary data on
the patients who were originally identified from the DCRA,
with 3879 of 4216 potentially eligible patients (92.0%) identi-
fied. Fig. 1s (see online-only Supplementary Material) shows
the number of patients who were excluded for each reason. A
total of 510 patients who underwent a BTS approach remained
for final analyses, of whom 182 underwent SEMS placement
(35.7%) and 328 underwent construction of a decompressing
stoma (64.3%).
Baseline characteristics for SEMS and decompressing stoma
patients are displayed in ▶Table1. The median bridging inter-
val to elective resection was 23 days (IQR 13–31) for SEMS and
36 days (IQR 22–65) for decompressing stoma patients. The
percentage of patients undergoing surgery after different brid-
ging intervals is displayed for the SEMS and decompressing sto-
ma groups in ▶Fig. 1. Long bridging intervals ( > 6 weeks) were
mainly observed in the decompressing stoma group (43.6% of
decompressing stoma patients). Of decompressing stoma pa-
tients with an interval > 6 weeks, 45 (35.2%) received neoadju-
vant therapy (not shown).
During the bridging interval, 11 SEMS (6.7%) and 23 decom-
pressing stoma patients (7.7%) were parenterally fed, while 14
SEMS (8.5%) and 12 decompressing stoma patients (4.1%) re-
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▶ Fig. 1 Percentage of patients in each group undergoing surgery
after the different bridging intervals.
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▶Table 1 Baseline characteristics, procedural indicators, and treat-
ment outcomes.
Bridge to elective surgery
SEMS
(n=182)
Decompres-
sing stoma
(n=328)
Male sex, n/N (%) 107/182
(58.8)
193/328
(58.8)
Median age (IQR), years 72.0
(63.8–81.0)
68.0
(59.0 –76.8)
Mean BMI (SD), kg/m2 25.7 (4.5) 25.3 (4.2)
ASA score, n/N (%)
▪ ASA 1 40/178
(22.5)
44/328
(13.4)
▪ ASA 2 98/178
(55.1)
212/328
(64.6)
▪ ASA 3 37/178
(20.8)
67/328
(20.4)
▪ ASA 4 3/178
(1.7)
5/328
(1.5)
Comorbidity, n (%) 128/180
(71.1)
232/328
(70.7)
Previous abdominal surgery,
n/N (%)
39/179
(21.8)
123/328
(37.5)
Tumor localization, n/N (%)
▪ Splenic flexure 11/182
(6.0)
52/328
(15.9)
▪ Descending colon 42/182
(23.1)
54/328
(16.5)
▪ Sigmoid 129/182
(70.9)
222328
(67.7)
Median interval from initial
therapy to resection (IQR), days
23.0
(13.0–31.0)
36.0
(22.0 –64.5)
Parenteral feeding during
bridging interval, n/N (%)
11/163
(6.7)
23/300
(7.7)
Enteral tube feeding during
bridging interval, n/N (%)
14/165
(8.5)
12/296
(4.1)
Neoadjuvant therapy during
bridging interval, n/n (%)
3/182
(1.6)
52/328
(15.9)
▪ Systemic therapy 1/176
(0.6)
49/317
(15.5)
▪ Radiation therapy 2/176
(1.1)
20/318
(6.3)
Discharge from hospital during
bridging interval, n/N (%)
134/172
(77.9)
278/312
(89.1)
Type of resection, n/N (%)
▪ Sigmoid resection 113/182
(62.1)
201/328
(61.3)
▪ Left hemicolectomy 64/182
(35.2)
99/328
(30.2)
▶Table 1 (Continuation)
Bridge to elective surgery
SEMS
(n=182)
Decompres-
sing stoma
(n=328)
▪ Subtotal colectomy 3/182
(1.6)
19/328
(5.8)
▪ Extended left hemicolectomy 1/182
(0.5)
7/328
(2.1)
▪ Transverse colectomy 1/182
(0.5)
2/328
(0.6)
Laparoscopic resection, n/N (%) 91/179
(50.8)
161/327
(49.2)
Converted laparoscopic resec-
tion, n/N (%)
19/64
(29.7)
27/157
(17.2)
Primary anastomosis, n/N (%) 152/181
(84.0)
280/327
(85.6)
Stoma directly after resection,
n/N (%)
37/175
(21.1)
214/326
(65.6)
Resection-related complications
< 90 days, n/N (%)
51/178
(28.7)
81/323
(25.1)
▪ Anastomotic leakage 16/152
(10.5)
15/280
(5.4)
▪ Intra-abdominal abscess 10/182 (5.5) 11/326
(3.4)
▪ Fascial dehiscence 11/177
(6.2)
5/311
(1.6)
▪ Wound infection 13/176
(7.4)
33/315
(10.5)
▪ Ileus 7/176
(4.0)
10/313
(3.2)
▪ Gastroparesis 7/176 (4.0) 6/312 (1.9)
▪ Bleeding 2/176 (1.1) 3/313 (1.0)
▪ Abdominal wall abscess 3/176 (1.7) 2/311 (0.6)
Median post-resection hospital
stay (IQR), days
7.0
(5.0–12.0)
7.0
(5.0–10.0)
90-day mortality, n/N (%) 10/182 (5.5) 8/328 (2.4)
3-year disease free survival, % 63.0 61.3
▪ Cumulative events at 36
months
58 95
▪ Patients at risk at 36 months 87 96
3-year overall survival, % 73.0 76.2
▪ Cumulative events at 36
months
42 53
▪ Patients at risk at 36 months 98 110
ASA, American Society of Anesthesiologists; BMI, body mass index; IQR, in-
terquartile range; SD, standard deviation; SEMS, self-expandable metal
stent.
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ceived enteral tube feeding. Neoadjuvant therapy during the
bridging interval was applied in 3 SEMS (1.6%) and 52 decom-
pressing stoma patients (15.9%), mainly consisting of systemic
therapy. The median follow-up was 43.5 months (IQR 17.0–
66.0) for the SEMS group and 25.0 months (IQR 14.8–46.3)
for the decompressing stoma group.
Procedural and outcome parameters
Cumulative incidence curves revealed peaks with higher rates
of 90-day post-resection complications if resection was per-
formed within 2 weeks of colonic decompression, especially
after decompressing stoma. These rates stabilized at a lower
level from a bridging interval of 15 days onwards (▶Fig. 2a).
After the exclusion of patients who underwent emergency
resection at < 48 hours because of SEMS failure, 23 patients de-
veloped SEMS-related complications. Overall, SEMS-related
perforations occurred in 12 patients (12 /169 [7.1%]; missing
data in 13 patients), including three with clinically overt per-
forations, eight with SEMS perforations that were intraopera-
tively identified during resection, and one with a perforation
that was found histopathologically. Visual evaluation of the
graphical data regarding SEMS-related complications showed
a peak for a bridging interval of about 1 week, with stabilization
at a lower level for bridging intervals of more than 4 weeks
(▶Fig. 2b). The median time from SEMS placement to SEMS-
related complication was 7.0 days (IQR 5.0–20.0).
Cumulative incidence curves of laparoscopic approach re-
vealed an increase with increasing bridging interval up to 5
weeks after decompressing stoma and stabilization thereafter,
while this influence of bridging interval was less clear after
SEMS placement (▶Fig. 2c). Similarly, primary anastomoses
were increasingly performed with longer bridging intervals,
with stabilization from 3 to 4 weeks onwards, which was more
pronounced after decompressing stoma (▶Fig. 2d).
Comparisons of bridging intervals
The different procedural and outcome parameters of the SEMS
and decompressing stoma groups are displayed in ▶Table2 for
the different prespecified bridging intervals, depending on the
type of intervention. These outcome parameters were also cal-
culated for 1-week increments of the bridging interval until 34
days and for the remaining group who underwent resection
after > 34 days, thereby providing detailed data that enable
other explorative analyses or pooling of data (Table1s).
SEMS group
The 90-day post-resection complication rate was lower for a
bridging interval of 11–17 days compared with 5–10 days, al-
though this did not reach statistical significance (25.0% vs.
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▶ Fig. 2 Cumulative percentage graphs of patients who had, with increasing bridging intervals: a a resection-related complication; b a self-
expandable metal stent (SEMS)-related complication; c a laparoscopically performed resection; d a primary anastomosis.
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▶Table 2 Procedural characteristics and treatment outcomes for SEMS and decompressing stoma as a bridge to elective surgery, stratified for different
bridging intervals.
Self-expandable metal stent (SEMS)
Bridging interval, days P value
5–10
(n =24)
11– 17
(n =38)
> 17
(n =112)
Overall 5–10 vs.
11 –17
11–17
vs. > 17
5–10 vs.
> 17
Procedural characteristics
Discharge from hospital during bridging
interval, n/N (%)
6/22 (27.3) 31/37 (83.8) 97/105 (92.4) < 0.001 <0.001 0.20 <0.001
Laparoscopic resection, n/N (%) 7/24 (29.2) 18/37 (48.6) 62/110 (56.4) 0.052 0.13 0.42 0.02
Conversion of laparoscopic resection,
n/N (%)
2/4 (50.0)1 5/11 (45.5)2 11/46 (23.9)3 0.21 >0.99 0.26 0.28
Primary anastomosis, n/N (%) 19/24 (79.2) 32/38 (84.2) 96/112 (85.7) 0.72 0.74 0.82 0.53
Stoma in situ directly after resection,
n/N (%)
9/23 (39.1) 6/36 (16.7) 19/109 (17.4) 0.07 0.053 0.92 0.046
Outcome variables
Resection-related complications
< 90 days, n/N (%)
10/24 (41.7) 9/36 (25.0) 31/111 (27.9) 0.33 0.17 0.73 0.18
SEMS-related complication4, n/N (%) 7/21 (33.3) 5/35 (14.3) 11/105 (10.5) 0.02 0.11 0.55 0.01
▪ Clinically overt perforation 1 1 1
▪ Perforation identified during resection 2 2 4
▪ Perforation identified during patholo-
gical examination
1 0 0
▪ Migration 2 1 1
▪ Obstruction 1 1 6
▪ Rectal bleeding 0 0 1
▪ Rectal/abdominal pain 1 0 2
Median post-resection hospital stay (IQR),
days
8.0 (5.0–15.3) 6.0 (4.0– 8.0) 7.0 (5.0–12.0) 0.25 0.12 0.25 0.30
Adjuvant chemotherapy, n/N (%) 8/23 (34.8) 19/38 (50.0) 39/112 (34.8) 0.24 0.25 0.10 >0.99
90-day mortality, n/N (%) 1/24 (4.2) 1/38 (2.6) 8/112 (7.1) 0.55 >0.99 0.45 >0.99
3-year disease free survival, %5 49.7 78.1 62.0 0.31 0.14 0.19 0.60
3-year overall survival, %5 63.2 80.7 72.8 0.48 0.27 0.27 0.75
Decompressing stoma
Bridging interval, days P value
< 14
(n =28)
14– 28
(n =92)
> 28
(n =187)
Overall < 14 vs.
14 –28
14–28
vs. > 28
<14 vs. >
28
Procedural characteristics
Discharge from hospital during bridging
interval, n/N (%)
10/27 (37.0) 77/90 (85.6) 178/181
(98.3)
< 0.001 <0.001 < 0.001 <0.001
Laparoscopic resection, n/N (%) 8/28 (28.6) 58/92 (63.0) 85/186 (45.7) 0.002 0.001 0.006 0.09
Conversion of laparoscopic resection,
n/N (%)
1/7 (14.3) 12/58 (20.7) 13/82 (15.9) 0.81 >0.99 0.46 >0.99
Primary anastomosis, n/N (%) 21/28 (75.0) 84/91 (92.3) 158/187
(84.5)
0.047 0.01 0.07 0.27
Stoma in situ directly after resection,
n/N (%)
19/27 (70.4) 64/92 (69.6) 119/186
(64.0)
0.58 0.94 0.36 0.52
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41.7%; P=0.17) (▶Table 2). The post-resection complication
rate did not significantly differ between the cutoff values of
11–17 and >17 days. A trend towards shorter post-resection
hospital stay was observed for a bridging interval of 11–17
days vs. 5–10 days (6 vs. 8 days; P=0.12). Of the 12 SEMS-
related perforations, five were observed in patients being oper-
ated on beyond 17 days, as were 6/8 SEMS obstructions. Of all
23 patients with SEMS-related complications, 11 (48%) under-
went resection with an interval of > 17 days.
The proportion of laparoscopic surgery increased with long-
er bridging intervals (29.2% for 5–10 days; 48.6% for 11–17
days; 56.4% for > 17 days), although this did not reach statisti-
cal significance. Fewer patients had a stoma in situ directly after
resection following a bridging interval of 11–17 days compar-
ed with 5–10 days (16.7% vs. 39.1%; P=0.053). No significant
differences were observed for 90-day mortality, 3-year disease-
free survival, or 3-year overall survival.
Decompressing stoma group
No significant differences in post-resection complication rates
were observed for any of the cutoff values (▶Table2). Resec-
tions were more often performed laparoscopically when wait-
ing 14–28 days compared with <14 days (63.0% vs. 28.6%; P
=0.001). The laparoscopy rate decreased to 45.7% in patients
who underwent resection beyond 28 days (P=0.006). Resec-
tion 14–28 days after initial decompressing stoma resulted in
significantly more primary anastomoses (92.3% vs. 75.0%; P=
0.01). Post-resection hospital stay was shorter if resection was
performed in the period of 14–28 days after decompression
when compared with resection within 14 days (7 vs. 10 days;
P=0.03), although this was not statistically significant after
correction for multiple testing (P>0.025). No significant differ-
ences were observed for 90-day mortality, 3-year disease-free
survival, or 3-year overall survival.
Discussion
This large population-based cohort study evaluated ESGE
guideline recommendations regarding bridging interval follow-
ing colonic stenting and explored clinically relevant bridging in-
tervals after decompressing stoma. Following SEMS, fewer
post-resection complications, shorter post-resection hospital
stay, and more laparoscopic resections were observed with tu-
mor resection performed 11–17 days after initial decompres-
sion compared with resection after 5–10 days, although not
reaching statistical significance. Almost half of the SEMS-relat-
ed complications, including five perforations and six obstruc-
tions, occurred in patients who underwent resection beyond
17 days.
Bridging intervals following decompressing stoma were
generally longer than after SEMS (median 36 vs. 23 days), and
15% of decompressing stoma patients underwent neoadjuvant
treatment for locally advanced colon cancer with delayed re-
section. If compared with resection within 14 days, a bridging
interval of 14–28 days following decompressing stoma resul-
ted in significantly more laparoscopic resections, more primary
anastomoses, and shorter post-resection hospital stays. No im-
pact of bridging intervals on postoperative mortality, disease-
free survival, or overall survival could be demonstrated.
Literature on the bridging interval following SEMS place-
ment or creation of a decompressing stoma is scarce. A single
institutional series by Matsuda et al. [12] analyzed 47 patients
with a SEMS followed by resection (two patients with stent mi-
gration were excluded). Eight patients developed post-resec-
tion complications with a Clavien–Dindo score ≥2 [13]. For re-
section performed at ≤15 days, 7/19 patients (37%) developed
postoperative complications, compared with 1/28 patients (4
%) who underwent surgery beyond 15 days (odds ratio [OR]
13.0; 95% confidence interval [CI] 1.01–167.0). These findings
are in line with the present study, although the effect size and
significance levels are fundamentally different.
Decompressing stoma (Continuation)
Outcome variables
Resection-related complications < 90 days,
n/N (%)
8/27 (29.6) 20/90 (22.2) 48/186 (25.8) 0.69 0.43 0.52 0.67
Median post-resection hospital stay (IQR),
days
10.0
(6.0– 18.8)
7.0
(4.8–9.3)
7.0
(5.0–10.0)
0.07 0.03 0.37 0.06
Adjuvant chemotherapy, n/N (%) 11/28 (39.3) 42/89 (47.2) 69/185 (37.3) 0.29 0.46 0.12 0.84
90-day mortality, n/N (%) 2/28 (7.1) 2/92 (2.2) 4/187 (2.1) 0.26 0.23 > 0.99 0.18
3-year disease free survival, %5 67.1 64.0 59.6 0.87 0.67 0.60 0.91
3-year overall survival, %5 71.0 80.3 75.4 0.68 0.57 0.39 0.92
IQR, interquartile range; NA, not applicable.
1 Data missing in 3 patients.
2 Data missing in 7 patients.
3 Data missing in 16 patients.
4 More than one complication per patient could be registered.
5 Log-rank test.
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In a comparative analysis of 43 patients who underwent
SEMS placement followed by elective resection, Lee et al. [14]
found a significant association between bridging interval and
anastomotic leakage: 3/15 patients with an interval of 1–9
days and 0/28 patients with an interval ≥10 days. In the Stent-
in II trial [15], a leak rate of 5/21 patients (24%) was observed
with a recommended bridging interval in the study protocol be-
tween 5 and 14 days, and the authors speculated that a longer
wait could have improved results. The only contradictory find-
ing in the literature is by Ho et al. [16], who reported on only 14
patients who had successful SEMS placement with a median of
10 days until elective resection. Without any supporting data,
they state that an interval between 9 and 14 days might be op-
timal with a higher risk of dense fibrotic adhesions at the level
of the stent after 14 days of waiting, which might complicate
surgery.
One study specifically analyzed the association between
bridging interval and oncological outcome [17]. In this study,
20/112 patients (18%) had stent-related complications requir-
ing emergency surgery, consisting of perforation and migration
in 10 patients each. The overall recurrence rate was 37%. Using
the median bridging interval of 18 days as a cutoff, a longer
bridging interval was significantly associated with overall tumor
recurrence, with an OR of 2.6 (95%CI 1.1–6.5) for the inten-
tion-to-treat population and an OR of 5.1 (95%CI 1.6–15.8)
after correction for age, sex, T-stage, and adjuvant chemother-
apy. This is in contrast to the present study, in which no differ-
ences in disease-free survival were observed among the differ-
ent bridging interval groups.
Regarding the decompressing stoma group, similar analyses
are lacking in the current literature. Jiang et al. [18] reported on
90 patients with a decompressing stoma as a BTS, with a mean
interval of 16 days (range 3–73 days). In the randomized trial
by Kronborg et al. [19], the study protocol described a 2-week
bridging interval between decompressing stoma and subse-
quent resection, but they did not provide data on the bridging
intervals. A recent single-center cohort study described a medi-
an 25 days (IQR 17–47) between colostomy and resection
among 85 patients [4]. Oistamo et al. [20] described the long-
est bridging interval, with a mean of 37 days in a group of 20
patients. None of these studies on decompressing stoma as a
BTS included any analysis regarding the association between
bridging interval and outcome.
Physicians likely had specific reasons for each particular brid-
ging interval based on their patient’s condition, age, tumor
stage, and other logistical aspects, resulting in allocation bias.
Only a randomized controlled trial (RCT) would solve this meth-
odological issue. In patients with LSOCC, RCTs are apparently
difficult to conduct, as illustrated by the published literature to
date. Clear preferences of doctors and patients regarding the
type of bridging technique and certain bridging intervals would
likely result in limited protocol adherence. RCTs in this setting
are often characterized by slow accrual and restricted external
validity as a result of strict and narrow inclusion criteria.
The findings of this study, together with the scarcity of avail-
able evidence from the literature, suggest that a 2-week gap to
definitive surgery is recommended in order for patients to ben-
efit from a decompressing intervention, and a prolonged wait-
ing period seems not to be associated with higher oncological
risks. Improvements in a patient’s general and surgical condi-
tion need some time, as illustrated by ▶Fig. 2. This is reflected
by the continuing increase in the proportion of primary anasto-
moses up to a 4-week bridging interval, especially after decom-
pressing stoma. The main limitation for longer waiting con-
cerns SEMS-related complications. Among the SEMS-related
complications, perforation is actually the most severe one that
should guide clinical decision-making. Stent obstruction may
be endoscopically managed [12], and stent migration might
prohibit further waiting, but without the worsening oncologi-
cal outcome.
After successful SEMS placement, a 2-week interval probably
results in the optimal balance between better surgical condi-
tion on the one hand and prevention of SEMS-related complica-
tions on the other hand. By following an approximately 2-week
interval, which is according to the most recent update of the
ESGE guideline [9], five SEMS-related perforations may have
been prevented, along with prevention of other complications
such as obstruction. Furthermore, the largest gain in minimally
invasive approach and bowel continuity has likely been reached
by that time.
After creation of a decompressing stoma, there is less ur-
gency to perform the resection, and an interval of 2–4 weeks
appeared to be associated with clinical benefits in terms of la-
paroscopic approach, bowel continuity, and hospital stay. Striv-
ing for more laparoscopic resections is worthwhile, not only be-
cause of enhanced recovery, but also because of long-term ad-
vantages, such as fewer incisional hernias and adhesion-related
small-bowel obstruction compared with open resections [21–
23]. Of course, neoadjuvant therapy would dictate the length
of the bridging interval in appropriate patients, and such pa-
tients with locally advanced disease are less likely to undergo
laparoscopy.
The limitations of the current study include the retrospec-
tive study design with its inherent methodological shortcom-
ings. Arguments for choosing a specific bridging interval were
unknown. Allocation bias might have affected the results ob-
served in the current study. Furthermore, the DCRA includes
only patients who underwent tumor resection. Patients who
died during the bridging interval were therefore not included
in the current study, which might have caused overly optimistic
results. As few [4] to no deaths [24] during the bridging interval
have been reported so far for decompressing stoma and SEMS
placement in the curative setting, we do not expect a large in-
fluence on our results. Additionally, we excluded patients who
did not achieve clinical success within 48 hours after bridging, a
timeframe that was chosen arbitrarily. As a result, the group of
patients with an interval < 1 week might still include patients
with unsuccessful colonic decompression. Regarding testing
for statistical significance, one should keep in mind the poten-
tial type 1 and 2 errors, which underlines the need for careful
interpretation. Finally, despite some data on parenteral or ent-
eral tube feeding being available, little was known on prehabili-
tation measures and improvement of patients’ clinical condi-
tion, such as gain in body weight, during the bridging interval.
Veld Joyce Valerie et al. Bridging interval to obstructive left colon cancer resection… Endoscopy | © 2020. Thieme. All rights reserved.
Original article
D
ow
nl
oa
de
d 
by
: U
ni
ve
rs
ite
it 
Le
id
en
 / 
LU
M
C
. C
op
yr
ig
ht
ed
 m
at
er
ia
l.
In conclusion, this large national cohort of patients with
LSOCC shows that surgical conditions for elective resection im-
proved with intervals of up to 4 weeks after SEMS placement or
stoma creation, as reflected by increasing rates of laparoscopic
resection and primary anastomosis. An optimized balance be-
tween SEMS-related complications and recovery of the patient
with optimized surgical conditions is probably achieved by
scheduling the resection after approximately 2 weeks following
successful SEMS placement. After creation of a decompressing
stoma, a bridging interval of 2–4 weeks is suggested.
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